Innoviva (INVA) Misses Q1 EPS by 7c

Innoviva (NASDAQ: INVA) reported Q1 EPS of $0.19, $0.07 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $40.5 million versus the consensus estimate of $47.06 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral